Semi-synthesis of TDP-43 reveals the effects of phosphorylation in N-terminal domain on self-association
Year: 2025
Type: article
Abstract: TDP-43, a nucleocytoplasmic shuttle protein consisting of 414 residues, forms self-association in the nucleus for physiological gene regulation, while aggregation into amyloid (consisting of aberrant β-sheets) in the cytoplasm causes neurodegenerative diseases such as amyotrophic lateral sclerosis. Post-translational phosphorylation of TDP-43 alters the self-association properties, which affects both the physiological function in the nucleus and the amyloidogenic potential in the cytoplasm, thereby impacting upon disease progression. However, insight into the role of per-residue phosphorylation in the self-association remains limited due to the difficulty in obtaining site-specifically phosphorylated TDP-43. Here, we demonstrate semi-synthesis of full-length TDP-43 that is uniformly phosphorylated at the 48th serine residue (designated as TDP1-414[pS48]). The synthetic scheme consisting of native chemical ligation followed by His-tag affinity chromatography efficiently gave TDP1-414(pS48) with a high purity. Interestingly, unlike non-phosphorylated TDP-43, the phosphorylated TDP-43 was found to have weak self-association property and to form aggregates that were not typical amyloid fibrils. Furthermore, chemical synthesis and three-dimensional structure analysis of the N-terminal domain (NTD, corresponding to TDP1-80) suggested that the phosphate ion at Ser48 weakens the inter-NTD interaction by inducing electrostatic repulsion. It significantly advances understanding of the pathological mechanisms involved in the post-translational modifications of TDP-43 associated with the neurodegenerative diseases. TDP-43 aggregation in the cytoplasm is linked to neurodegenerative diseases, yet the impact of specific phosphorylation sites on its self-association remains unclear. Here, the authors synthesize TDP-43 phosphorylated at Ser48, revealing altered aggregation properties and providing insights into the pathological mechanisms of TDP-43 modifications in disease progression.
Source: Communications Chemistry
Authors: Daisuke Sasaki, Mao Tenda, Youhei Sohma
Institution: Wakayama Medical University
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,690
Funders: Japan Agency for Medical Research and Development, Hoansha Foundation, Ministry of Education, Culture, Sports, Science and Technology, Wakayama Medical University, Astellas Pharma, Astellas Foundation for Research on Metabolic Disorders, Chugai Pharmaceutical, Japan Society for the Promotion of Science
Awards: G1330001107, G1725708031, G2597338402, G2720596666, G3525255350, アミロイドを解明・治療・利用する化学研究, G3978516678, G4299315364, Elucidation of structural basis for pathogenicity by a post-translatinally modified TDP-43, an ALS facor, Development of innovative aggregation inhibition strategies for amyloid proteins that cause neurodegenerative diseases, G938635837
OpenAlex ID: W4409785944
